A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …

J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD),
with a reference preparation containing a similar dose of gestodene but in combination with
30 μg ethinylestradiol. A higher incidence of intermenstrual bleeding was apparent under
the 20 μg EE2 oral contraceptive. For the 20 μg EE2 preparation, 47.4% of all women
reported spotting at least once over a period of 12 treatment cycles, whereas this figure was …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol …

J Endrikat, MA Jaques, M Mayerhofer, C Pelissier… - Contraception, 1995 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a
reference preparation containing the same dose of estrogen combined with 150 μg
desogestrel. This article presents interim data from centers in France and Austria, involving a
total of 479 women and 4,991 cycles. Contraceptive reliability was good with both
preparations. Two pregnancies occurred in the gestodene group, but neither were due to …
以上显示的是最相近的搜索结果。 查看全部搜索结果